Haystack MRD® is an advanced tumor-informed minimal residual disease (MRD) test that detects ctDNA in blood with exceptional sensitivity and specificity.

Joined June 2022
379 Photos and videos
One of our #ASCO26 posters (532) shows high concordance between ctDNA and ctHPV-DNA in HPV-driven oropharyngeal cancers, with ctDNA clearing faster than HPV in patients who were undergoing treatment. Learn more: hubs.la/Q04jjMXs0 #ctDNA #MRD
2
1
88
Heading to #ASCO26? Visit our poster on ptDNA in gastroesophageal cancer to see how next-generation sequencing is being used in innovative ways to advance personalized care. May 30, 9:00 AM-12:00 PM, poster 84. hubs.la/Q04jhSKk0 #ctDNA #MRD
81
Research collaborators are presenting new data at ASCO using Haystack MRD in 2 new disease types – gastric cancer and head and neck cancer. Learn more about the abstracts being presented and meet Confidence, your Haystack Hero. hubs.la/Q04hX8_V0 #ASCO26 #ctDNA #MRD
1
94
Confidence changes how you move forward in cancer care. At #ASCO, see how Haystack MRD brings the clarity behind more confident clinical decisions. Visit the Quest Diagnostics booth 10109 to meet Confidence—the Haystack Hero for #ctDNA testing. Learn more: nam04.safelinks.protection.o…
1
1
36
See our poster presentation, “Real-world utilization of molecular residual disease testing in cancer care,” at #ONSCongress today: 11:25 AM–11:35 AM at Tower View Registration, Poster pavilion, Poster monitor 15. #ctDNA #MRD
41
Scientific session spotlight at the 2026 ONS Congress: “Real-world utilization of molecular residual disease testing in cancer care,” May 14 from 11:25 AM–11:35 AM at Tower View registration, Poster Pavilion, poster monitor 15. #ctDNA #MRD #ONSCongress
49
From clinical practice to clinical research, Haystack MRD® delivers exceptionally accurate ctDNA detection. See you at COA 2026 in Orlando. hubs.la/Q04dHP7q0 #COA2026 #MRD #ctDNA
49
Visit Quest Diagnostics® booth 808 at COA 2026 to learn how Haystack MRD® supports real-time treatment monitoring. hubs.la/Q04dHDly0 #COA2026 #MRD #ctDNA
55
Biopharma teams: Haystack MRD® can support your oncology trials through ctDNA-guided patient enrichment and stratification. Let’s connect at COA 2026. hubs.la/Q04dHDd10 #COA2026 #MRD #ctDNA
40
Oncology professionals—stop by Quest Diagnostics® booth 808 at the 2026 COA conference to explore ctDNA testing options with Haystack MRD®. hubs.la/Q04dHD5w0 #COA2026 #MRD #ctDNA
42
Haystack MRD® helps clinicians detect recurrence, make treatment decisions, and monitor treatment response. Let’s connect at #COA2026—Quest Diagnostics® booth 808. Learn more: hubs.la/Q04dhQCp0
24
Better insights can lead to better outcomes. See how Haystack MRD® by Quest Diagnostics® provides confidence and clarity to help guide treatment decisions. We’ll be at booth 118 at #SGOAM26. Learn more: hubs.la/Q04b0yW60 #ctDNA #MRD #HaystackMRD
2
107
We're excited to connect with the gynecologic oncology community at #SGOAM26. Find us at Quest Diagnostics® booth 118 to chat about ultrasensitive ctDNA testing. Learn more: hubs.la/Q04b0vw20 #ctDNA #MRD #HaystackMRD
109
Identifying patients at high risk of relapse is critical. Learn how Haystack MRD® is helping clinicians do just that at Quest Diagnostics® booth 118 at #SGOAM26. Learn more: hubs.la/Q04b0rXZ0 #ctDNA #MRD #HaystackMRD
1
91
Haystack MRD® offers exceptional accuracy and confidence in results. Let's discuss what that means for your practice at #SGOAM26. Find us at the Quest Diagnostics® booth 118. Learn more: Learn more: hubs.la/Q04b0sGV0 #ctDNA #MRD #HaystackMRD
54
Planning your schedule for #SGOAM26? Make sure to add a visit to Quest Diagnostics® booth 118 to your list and learn how our exceptionally accurate ctDNA testing is being used in gynecological cancers. Learn more: hubs.la/Q04b0nSm0 #ctDNA #MRD #HaystackMRD
70
Heading to #SGOAM26 in San Juan? Visit the Quest Diagnostics® booth 118 to learn how Haystack MRD® delivers confidence through exceptionally accurate ctDNA detection. Learn more: hubs.la/Q04b0qH50 #ctDNA #MRD #HaystackMRD
54
A New England Journal of Medicine study showed how ctDNA testing helped monitor treatment response in real time—without surgery, radiation, or chemo. Watch Dr. Andrea Cercek discuss the results 👉 hubs.la/Q041SHCK0 #CancerResearch #ctDNA #MRD #OncologyInnovation
42